KKRC
ENTL

Kohlberg Kravis Roberts & Co’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,405,380
Closed -$34.3M – 50
2017
Q4 		$34.3M Hold
1,405,380
– – 0.34% 23
2017
Q3 		$25.9M Buy
+1,405,380
New +$24.3M 0.3% 27

Kohlberg Kravis Roberts & Co's ENTL Position: Q1 2018 in Review

Kohlberg Kravis Roberts & Co sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 1,405,380 shares — an estimated $34.3M sold.

Kohlberg Kravis Roberts & Co first reported a position in ENTL in Q3 2017 and held it in 2 quarters. The position peaked at $34.3M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Kohlberg Kravis Roberts & Co reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 1,405,380 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $34.3M.
  • Kohlberg Kravis Roberts & Co first reported a position in Entellus Medical, Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Kohlberg Kravis Roberts & Co's Entellus Medical, Inc. Common Stock position peaked at $34.3M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q1 2018, filed 15 May 2018.